J. G. Sarmiento

发表

Binding of nitrendipine (BAY e 5009), a calcium entry blocker, to cardiac membranes

David J. Triggle, R. A. Janis, J. G. Sarmiento, 1982 .

The Dihydropyridine Receptors

J. G. Sarmiento, D. Triggle, P. Bellemann, 1985 .

Photoaffinity labelling of a 33-35,000 dalton protein in cardiac, skeletal and smooth muscle membranes using a new 125I-labelled 1,4-dihydropyridine calcium channel antagonist.

J. G. Sarmiento, D. W. Chester, H. Smilowitz, 1986, Life sciences.

Possible Mechanism for Cardiovascular Drug — Membrane Interactions

J. G. Sarmiento, A. Katz, D. Rhodes, 1985 .

Identification of high and low (GTP-sensitive) affinity [3H]glibenclamide binding sites in cardiac ventricular membranes.

J. G. Sarmiento, J. F. French, L. Riera, 1990, Biochemical and biophysical research communications.

Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site.

J. G. Sarmiento, D. Rhodes, L. Herbette, 1985, Molecular pharmacology.

Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.

J. G. Sarmiento, A. Katz, D. Triggle, 1983, Journal of molecular and cellular cardiology.

Binding of [3H]nimodipine to cardiac and smooth muscle membranes.

J. G. Sarmiento, D. Triggle, G. Bolger, 1982, European journal of pharmacology.

Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.

J. G. Sarmiento, D. Triggle, G. Bolger, 1984, The Journal of pharmacology and experimental therapeutics.

Modulation of [3H]glibenclamide binding to cardiac and insulinoma membranes.

J. G. Sarmiento, U. L. Mullins, J. F. French, 1991, European journal of pharmacology.

Isosteric replacement in a series of β-substituted monophosphonate calcium antagonists

J. G. Sarmiento, M. Foley, J. Buyniski, 1993 .

Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.

J. G. Sarmiento, D. Triggle, R. Janis, 1984, The Journal of pharmacology and experimental therapeutics.

Preparation and in vitro biological evaluation of the enantiomers of the diydropyridine BMY 20014, a combination calcium and α1-adrenoreceptor antagonist

J. E. Lawson, J. G. Sarmiento, G. Poindexter, 1993 .

Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.

J. G. Sarmiento, D. Triggle, D. Rampe, 1984, Biochemical and biophysical research communications.

[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.

J. G. Sarmiento, D. Triggle, R. Janis, 1987, The Journal of pharmacology and experimental therapeutics.

Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.

J. G. Sarmiento, A. Katz, D. Triggle, 1984, Biochemical pharmacology.